Add to a list

Suspension of trading

CARMAT Share Price Börse Stuttgart

CXT

FR0010907956

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Delayed Börse Stuttgart			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

01/09	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris

Analysts' recommendations: CARMAT

09/25/09	Carmat: Invest Securities raises target price
11/25/11	Carmat: Invest Securities still a buyer, but cuts TP
04/25/04	Carmat: Invest Securities slightly lowers its target
09/25/09	Carmat: Invest Securities upgrades to buy
09/25/09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: CARMAT

04/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

More news

Managers and Directors: CARMAT

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	61.46L 69.92L 57.89L 52.91L 98.89L 67Cr 99.76L 6.94Cr 2.69Cr 34Cr 2.62Cr 2.57Cr 111.03Cr	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	5.92Cr 6.74Cr 5.58Cr 5.1Cr 9.53Cr 646.88Cr 9.62Cr 67Cr 26Cr 330.1Cr 25Cr 25Cr 1.07TCr	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01/09	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
06/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
06/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
04/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/25/15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/25/15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/25/15	Carmat says liquidation review postponed until Nov 25	RE
01/25/01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
04/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/25/29	CARMAT : Inside Information / Other news releases	PU
29/25/29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/25/15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	70.8L
STRYKER CORPORATION	-1.34%	-5.27%	-27.78%	-5.44%	10TCr
SMITH & NEPHEW PLC	-0.30%	-3.60%	-25.48%	-3.27%	1.12TCr
GLAUKOS CORPORATION	+0.91%	-5.25%	+82.88%	+105.74%	904.91Cr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.29%	+3.85%	-48.74%	-66.54%	419.8Cr
DOUBLE MEDICAL TECHNOLOGY INC.	-0.91%	+6.88%	-21.15%	+29.07%	251.37Cr
INSPIRE MEDICAL SYSTEMS, INC.	-0.36%	-5.42%	-10.68%	-62.81%	199.66Cr
INSIGHT LIFETECH CO., LTD.	-3.28%	+6.48%	-	-	200.57Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-1.43%	+0.79%	-19.92%	-27.50%	155.28Cr
Average	-0.58%	-1.02%	-10.13%	-4.39%	1.72TCr
Weighted average by Cap.	+1.04%	-3.57%	-20.38%	-0.19%

	2023	2024
Net sales	38.37L 43.65L 36.14L 33.03L 61.74L 42Cr 62.29L 4.33Cr 1.68Cr 21Cr 1.64Cr 1.6Cr 69Cr	73.44L 83.55L 69.17L 63.22L 1.18Cr 80Cr 1.19Cr 8.29Cr 3.22Cr 41Cr 3.14Cr 3.07Cr 132.68Cr
Net income	-5.39Cr -6.13Cr -5.07Cr -4.64Cr -8.67Cr -588.17Cr -8.74Cr -61Cr -24Cr -300.15Cr -23Cr -23Cr -973.24Cr	-5.14Cr -5.85Cr -4.84Cr -4.42Cr -8.27Cr -561.16Cr -8.34Cr -58Cr -23Cr -286.36Cr -22Cr -21Cr -928.54Cr
Net Debt	4.96Cr 5.65Cr 4.68Cr 4.27Cr 7.99Cr 541.95Cr 8.06Cr 56Cr 22Cr 276.56Cr 21Cr 21Cr 896.76Cr	5.31Cr 6.04Cr 5Cr 4.57Cr 8.54Cr 579.78Cr 8.62Cr 60Cr 23Cr 295.86Cr 23Cr 22Cr 959.35Cr

CARMAT Share Price Börse Stuttgart

Stocks

CXT

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: CARMAT

Latest news: CARMAT

Analysts' recommendations: CARMAT

Press Releases: CARMAT

News in other languages: CARMAT

Managers and Directors: CARMAT

Medical Devices & Implants

Financials

Company Profile